Skip to content

The effect on adjunctive Amoxicillin and Metronidazole during non-surgical periodontal treatment of patients with aggressive periodontitis

The effect on adjunctive Amoxicillin and Metronidazole during non-surgical periodontal treatment of patients with aggressive periodontitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007666
Enrollment
Unknown
Registered
2015-12-28
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aggressive periodontitis

Interventions

Generalized aggressive periodontitis group:Non-surgical periodontal treatment, including oral hygiene instruction, supragingival scaling, and quardrant-based subgingival scaling and root planing under

Sponsors

Peking University School and Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria forgeneralized aggressive periodontitisisaccording to the classification proposed at the International Workshop for the Classification of Periodontal Diseases and Conditions in 1999.The inclusion criteria of the generalized aggressive periodontitisgroup are: (1) The onset of the periodontal disease occurred under 35 years-old; (2) At least 8 teeth with probingdepth (PD)over 6 mm and attachment loss (AL) over 3 mm, at least 3 involved teethare not first molars or incisors; (3) Full mouth periapical radiographic evidence was present of alveolar bone loss; (4) At lease 20 functional teeth remained, at least 1 molar remained in every quadrant.

Exclusion criteria

Exclusion criteria: (1) Current or previous smoker; (2) A diagnosis of chronic periodontitis; (3) The presence of systemic disease or pregnant; (4) Drug allergy to penicillin or MET; (5) History of periodontal therapy or antimicrobial therapy within 6 months, or usage of any medication (including oral contraceptive drugs) within 3 months; (6) History of orthodontic treatment or noteworthy occlusal disharmony.

Design outcomes

Primary

MeasureTime frame
Probing depth;Attachment loss;Bleeding index;Plaque index;Tooth mobility;Putative periodontal pathogens in subgingival plaque;

Secondary

MeasureTime frame
Age;Gender;Body mass index;

Countries

China

Contacts

Public ContactMeng Huanxin
kqhxmeng@bjmu.edu.cn+86 10-82195368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026